97 related articles for article (PubMed ID: 2315924)
1. Toxicity of cadmium to rat osteosarcoma cells (ROS 17/2.8): protective effect of 1 alpha,25-dihydroxyvitamin D3.
Angle CR; Thomas DJ; Swanson SA
Toxicol Appl Pharmacol; 1990 Mar; 103(1):113-20. PubMed ID: 2315924
[TBL] [Abstract][Full Text] [Related]
2. Lead inhibits the basal and stimulated responses of a rat osteoblast-like cell line ROS 17/2.8 to 1 alpha,25-dihydroxyvitamin D3 and IGF-I.
Angle CR; Thomas DJ; Swanson SA
Toxicol Appl Pharmacol; 1990 Apr; 103(2):281-7. PubMed ID: 2330589
[TBL] [Abstract][Full Text] [Related]
3. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
[TBL] [Abstract][Full Text] [Related]
4. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
5. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
[TBL] [Abstract][Full Text] [Related]
7. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK
Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
9. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture.
Vernillo AT; Rifkin BR; Hauschka PV
Bone; 1990; 11(5):309-12. PubMed ID: 2252808
[TBL] [Abstract][Full Text] [Related]
11. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.
Lau KH; Yoo A; Wang SP
Mol Cell Biochem; 1991 Jul; 105(2):93-105. PubMed ID: 1922012
[TBL] [Abstract][Full Text] [Related]
12. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
Jurutka PW; Terpening CM; Haussler MR
Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128
[TBL] [Abstract][Full Text] [Related]
13. The effect of 1,25-dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells.
Gronowicz G; Egan JJ; Rodan GA
J Bone Miner Res; 1986 Oct; 1(5):441-55. PubMed ID: 3332554
[TBL] [Abstract][Full Text] [Related]
14. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
15. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
16. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of a novel vitamin D analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture.
Marie PJ; Connes D; Hott M; Miravet L
Bone; 1990; 11(3):171-9. PubMed ID: 2390375
[TBL] [Abstract][Full Text] [Related]
18. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
19. Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells.
Ryhänen S; Mahonen A; Jääskeläinen T; Mäenpää PH
Eur J Biochem; 1996 May; 238(1):97-103. PubMed ID: 8665957
[TBL] [Abstract][Full Text] [Related]
20. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells.
Long GJ; Rosen JF; Pounds JG
Toxicol Appl Pharmacol; 1990 Nov; 106(2):270-7. PubMed ID: 2256116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]